S&P 500 Futures
(0.14%) 5 334.50 points

Dow Jones Futures
(0.04%) 40 154 points

Nasdaq Futures
(0.21%) 18 675 points

Oil
(-0.31%) $79.81

Gas
(1.22%) $2.66

Gold
(0.93%) $2 439.90

Silver
(2.40%) $32.01

Platinum
(-0.28%) $1 087.00

USD/EUR
(0.07%) $0.920

USD/NOK
(0.01%) $10.68

USD/GBP
(0.06%) $0.788

USD/RUB
(-0.50%) $90.52

Realtime updates for Sanofi American [SNY]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—General

BUY

67.35%
return 1.38%

SELL

34.00%
return 0.68%

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

-0.31% $ 48.67

BUY 3891 min ago

@ $48.45

Issued: 17 May 2024 @ 14:42

Return: 0.46%

Previous signal: May 17 - 12:29

Previous signal: Sell

Return: -0.01 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally...

Stats
Today's Volume	838 711
Average Volume	1.98M
Market Cap	111.72B
EPS	$0 ( 2024-04-25 )
Next earnings date	( $0.890 ) 2024-07-26
Last Dividend	$1.903 ( 2023-05-30 )
Next Dividend	$0 ( N/A )
P/E	24.71
ATR14	$0.340 (0.70%)

Volume Correlation

Long: 0.71 (moderate)

Short: 0.95 (very strong)

Signal:(65) Expect same movement, but be aware

Sanofi American Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sanofi American Correlation - Currency/Commodity

-0.30
( neutral )

0.14
( neutral )

0.00
( neutral )

0.51
( weak )

0.17
( neutral )

0.26
( neutral )

Sanofi American Financials

Annual	2023
Revenue:	$43.07B
Gross Profit:	$26.50B (61.52 %)
EPS:	$4.31

FY	2023
Revenue:	$43.07B
Gross Profit:	$26.50B (61.52 %)
EPS:	$4.31

FY	2022
Revenue:	$45.39B
Gross Profit:	$31.70B (69.83 %)
EPS:	$6.69

FY	2021
Revenue:	$39.18B
Gross Profit:	$26.92B (68.72 %)
EPS:	$2.49

Financial Reports:

No articles found.

Sanofi American Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$3.28 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Sanofi American Dividend Information - Dividend Knight

Dividend Sustainability Score: 3.13 - low (4.25%) | Divividend Growth Potential Score: 5.65 - Stable (12.94%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.462	2003-05-28
Last Dividend	$1.903	2023-05-30
Next Dividend	$0	N/A
Payout Date	2023-06-23
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	$33.25	--
Avg. Dividend % Per Year	3.34%	--
Score	3.39	--
Div. Sustainability Score	3.13
Div.Growth Potential Score	5.65
Div. Directional Score	4.39	--

Next Divdend (Est)
(2025-02-10)

$1.985 Estimate 3.15 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.39

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	$0.462	1.49%
2004	$0.610	1.60%
2005	$0.799	2.01%
2006	$0.912	2.00%
2007	$1.145	2.48%
2008	$1.510	3.31%
2009	$1.419	4.34%
2010	$1.627	3.99%
2011	$1.822	5.55%
2012	$1.756	4.72%
2013	$1.862	3.89%
2014	$1.910	3.69%
2015	$1.618	3.55%
2016	$1.630	3.86%
2017	$1.577	3.84%
2018	$1.861	4.30%
2019	$1.739	4.06%
2020	$1.753	3.46%
2021	$1.906	3.91%
2022	$2.04	4.02%
2023	$3.28	6.69%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.123	1.500	7.54	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0961	1.500	-0.0433	-0.0649	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.54	1.000	8.69	8.69	[3 - 30]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.61	2.00	7.20	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.673	1.000	2.11	2.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.212	1.000	7.76	7.76	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.77	1.000	8.51	0	[1 - 100]
returnOnEquityTTM	0.0961	2.50	-0.0278	-0.0649	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.61	2.00	8.13	10.00	[0 - 30]
dividendYielPercentageTTM	8.21	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	4.24	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.179	1.000	8.03	0	[0.1 - 0.5]
Total Score				5.65

Sanofi American Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Sanofi American

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.